COCHLEAR LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.8 AUD | +0.24% |
|
+1.62% | +7.40% |
| 04-22 | Cochlear Limited Announces Company Secretary Changes | CI |
| 04-19 | Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old | CI |
Chart calendar Cochlear Limited
a959d4dd4a25c50f7e2ec6244411e.PHhy3efm5zecx0EVfyRfCFa_5ZblnAcLqbGiWf1HFS8.cQ8rj4uy3nyvsnhKPk4vOWX-r6625DFx-MXUHrxxbUhTST2o17aybuutcQ~5911272c711dca3d6c9584081f4c57d4
Upcoming events on Cochlear Limited
Past events on Cochlear Limited
| 20/03/2024 | Ex-dividend day for dividende intermédiaire |
| 18/02/2024 23:00 | Q2 2024 Earnings Call |
| 18/02/2024 20:30 | Q2 2024 Earnings Release |
| 26/10/2023 23:00 | Capital Markets Day |
| 17/10/2023 00:00 | Annual General Meeting |
| 17/09/2023 | Final dividend |
| 14/08/2023 | Q4 2023 Earnings Call |
| 14/08/2023 22:32 | Q4 2023 Earnings Release |
| 20/03/2023 | Ex-dividend day for dividende intermédiaire |
| 14/02/2023 23:00 | Interim 2023 Earnings Call |
| 14/02/2023 21:10 | Interim 2023 Earnings Release |
| 18/10/2022 00:00 | Annual General Meeting |
| 20/09/2022 | Ex-dividend day for final dividend |
| 18/08/2022 | FY 2022 Earnings Call |
| 18/08/2022 22:43 | FY 2022 Earnings Release |
| 27/03/2022 | Ex-dividend day for dividende intermédiaire |
| 21/02/2022 | Interim 2022 Earnings Call |
| 21/02/2022 21:24 | Interim 2022 Earnings Release |
| 19/10/2021 00:00 | Annual General Meeting |
| 22/09/2021 | Ex-dividend day for final dividend |
Past dividends on Cochlear Limited
| 20/03/2024 | Interim Payment 1.4 AUD |
| 20/03/2024 | Interim Payment 0.6 AUD |
| 17/09/2023 | Final Payment 1.225 AUD |
| 17/09/2023 | Final Payment 0.525 AUD |
| 20/03/2023 | Interim Payment 1.0075 AUD |
| 20/03/2023 | Interim Payment 0.5425 AUD |
| 20/09/2022 | Final Payment 0.87 AUD |
| 20/09/2022 | Final Payment 0.58 AUD |
| 27/03/2022 | Interim Payment 1.55 AUD |
| 22/09/2021 | Final Payment 1.4 AUD |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1 446 1 461 -1% | 1 352 1 264 6.97% | 1 493 1 497 -0.25% | 1 648 1 643 0.31% | 1 956 1 855 5.41% | 2 276 |
|
EBITDA Million AUD | Released Forecast Spread | 409 406 0.57% | 256 266 -3.74% | 410 416 -1.56% | 456 466 -2.16% | 477 481 -0.83% | 607 |
|
EBIT Million AUD | Released Forecast Spread | 370 368 0.55% | 207 151 37.37% | 330 343 -3.67% | 383 393 -2.52% | 396 405 -2.12% | 522 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 366 364 0.52% | -271 -200 -35.24% | 366 370 -1.21% | 394 398 -1.08% | 397 409 -3.07% | 534 |
|
Net income Million AUD | Released Forecast Spread | 277 268 3.29% | -238 -183 -30.39% | 327 322 1.47% | 289 294 -1.62% | 301 303 -0.67% | 392 |
|
EPS AUD | Released Forecast Spread | 4,80 4,66 2.99% | -4,00 -3,86 -3.5% | 4,97 4,78 3.9% | 4,40 4,45 -1.25% | 4,57 4,58 -0.3% | 5,98 |
| Announcement Date | 15/08/19 | 17/08/20 | 19/08/21 | 18/08/22 | 14/08/23 | - |
Quarterly results
| Fiscal Period | Juni | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 756 806 -6.21% | 575 532 8.06% | 743 695 6.83% | 751 719 4.4% | 815 788 3.5% | 833 815 2.19% | 885 862 2.66% | 1 071 963 11.21% | 1 099 1 113 -1.33% | 1 185 | 1 210 | 1 269 |
|
EBITDA Million AUD | Released Forecast Spread | 51,0 60,3 -15.42% | 213 130 63.19% | 197 206 -4.29% | 253 217 16.83% | 202 226 -10.33% | 223 227 -1.61% | 254 253 0.26% | 298 297 0.34% | 317 | |||
|
EBIT Million AUD | Released Forecast Spread | 184 200 -8.01% | 23,2 60,4 -61.56% | 176 136 29.59% | 155 155 -0.25% | 218 175 24.12% | 165 178 -7.27% | 186 188 -1.36% | 210 216 -2.47% | 255 250 1.86% | 262 | 292 | 308 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 239 118 101.86% | 127 162 -21.9% | 231 175 31.98% | 163 176 -7.21% | 188 187 0.48% | 260 257 1.33% | ||||||
|
Net income Million AUD | Released Forecast Spread | 158 146 8.09% | -396 -433 8.52% | 236 97,0 143.51% | 90,3 118 -23.38% | 169 132 28.45% | 120 126 -4.77% | 142 138 2.48% | 159 161 -1.36% | 191 192 -0.42% | 203 | 209 | 227 |
|
EPS AUD | Released Forecast Spread | 2,73 2,56 6.6% | -6,73 -0,29 -2218.97% | 3,59 1,48 142.12% | 1,38 1,75 -21.13% | 2,57 2,00 28.42% | 1,82 1,95 -6.7% | 2,15 2,08 3.34% | 2,42 2,44 -0.94% | 2,91 2,93 -0.6% | 3,04 | 2,97 | 3,82 |
| Announcement Date | 17/02/20 | 17/08/20 | 18/02/21 | 19/08/21 | 21/02/22 | 18/08/22 | 14/02/23 | 14/08/23 | 18/02/24 | - | - | - |
| 30/04/2024 06:00 | STRAUMANN HOLDING AG: Q1 2024 Earnings Release |
| 05/05/2024 | DEMANT A/S: Q1 2024 Sales and Revenue Release - Interim Management Statement |
| 14/05/2024 06:00 | SONOVA HOLDING AG: Q4 2024 Earnings Release |
| 23/07/2024 06:00 | EMBLA MEDICAL HF.: Q2 2024 Earnings Release |
| 13/08/2024 | STRAUMANN HOLDING AG: Q2 2024 Earnings Release |
| 13/08/2024 | DEMANT A/S: Q2 2024 Earnings Release |
| 14/08/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 14/08/2024 | COCHLEAR LIMITED: Q4 2024 Earnings Release |
| 21/08/2024 | ANGELALIGN TECHNOLOGY INC.: Q2 2024 Earnings Release (Projected) |
| 22/10/2024 06:00 | EMBLA MEDICAL HF.: Q3 2024 Earnings Release |
Past sector events for Cochlear Limited
| 23/04/2024 06:00 | EMBLA MEDICAL HF.: Q1 2024 Earnings Release |
| 17/04/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
| 17/04/2024 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
| 18/03/2024 | ANGELALIGN TECHNOLOGY INC.: Q4 2023 Earnings Release |
| 27/02/2024 06:00 | STRAUMANN HOLDING AG: Q4 2023 Earnings Release |
| 18/02/2024 20:30 | COCHLEAR LIMITED: Q2 2024 Earnings Release |
| 05/02/2024 16:45 | DEMANT A/S: Q4 2023 Earnings Release |
| 30/01/2024 07:00 | EMBLA MEDICAL HF.: Q4 2023 Earnings Release |
| 21/11/2023 06:00 | SONOVA HOLDING AG: Q2 2024 Earnings Release |
| 06/11/2023 | DEMANT A/S: Q3 2023 Sales and Revenue Release - Interim Management Statement |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- COH Stock
- Calendar Cochlear Limited
